Catalyze is the market leader in the Life Sciences field of:

  • Pharmaceuticals
  • Biotechnology
  • Diagnostics
  • Medical devices/MedTech
  • Regenerative medicine
  • E-health and big data

Our main goal is to support leading researchers and companies secure funding for ambitious R&D projects, from early stage, fundamental research up until late-stage development. In our strategy, we combine (inter)national subsidies and government-secured loans, entirely tailored to your ambitions and needs.

The development of disruptive innovations is a complex process, taking several years. To help you accelerate this process we can support you in the following ways: the development of your business case or business plan, conducting your market research, development of your funding strategy & roadmap and acquiring funding through grant programs and government-secured loans.

At Catalyze we have raised more than €600 million in funding and have a strong track record raising funding through, but not limited to, Horizon 2020,NIH, IMI, ERC, CARB-X, Eurostars, IMI,ERC, Department of Defense and various regional funds and patient organizations. Our team is also experienced in government secured loans, fiscal stimulus programs and raising.